Sema4 is the developer of an AI-driven patient-centered genomic and clinical data insight platform designed to to transform healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology.

Register for Details

For more details on financing and valuation for Sema4, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Sema4's ticker symbol?


What is Sema4's stock price?

0.3106 as of 1/9/23

Sema4 Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/29/2020 Series C $121.4MM raised $XXX.XX $XXX.XX
8/22/2019 Series B $127.61MM raised $XXX.XX $XXX.XX
3/21/2018 Series A-1 and A-2 $119.25MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Sema4

Forge green plus iconForge green minus icon

What is Sema4 funding to date?

Sema4 has raised $368.26MM to date.
Forge green plus iconForge green minus icon

When was Sema4 founded?

Sema4 was founded in 2015.
Updated on: Jun 12, 2022